Unlike tightly controlled clinical trials, real-life settings lack structured support, which often leads to lower adherence
This shift in speed is often the root cause of many common gastrointestinal side effects
Only 100% pure, pharmaceutical-grade L-Glutamine is selectedfor inclusion in our formulary
Figure 1: A metabolic use-case comprehensive patient journey view with taXonomy Pathways In clinical trials, GLP-1 drugs showed high adherence (over 85% of patients stayed on therapy), yet real-world use tells a different story: one large study found only 32% of obese patients remained on a GLP-1 therapy after one year, with just 27% meeting standard adherence thresholds
What were some of your key takeaways on multis, on the macro front
"There's nothing forcing their bones to kind of hold their weight anymore," he said